Cytosorbents(CH:CTSO)
CH:CTSO
Cytosorbents earnings date
Cytosorbents (CTSO) Q4 2022 Earnings Report
4 Followers
CH:CTSO Q4 2022 EPS Results
- Actual EPS
- -CHF 0.17
- Consensus EPS
- -CHF 2.81
- Beat/Miss
- Beat by +CHF 2.64
- One Year Ago EPS
- -CHF 3.51
CH:CTSO Q4 2022 Revenue Results
- Actual Revenue
- CHF 7.84M
- Expected Revenue
- CHF 7.28M
- Beat/Miss
- Beat by +CHF 567.56K
- YoY Revenue Growth
- -12.91%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 03/09/2023
- Time
- After Close
- Conference Call
- Thursday, March 9, 2023
CH:CTSO Upcoming Earnings
Cytosorbents's next earnings date is estimated for March 9, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
CH:CTSO Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:CTSO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 09, 2027 | 2026 (Q4) | -0.58- | -1.5 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.75-0.40 | -0.67 | 40.00% (+0.27) | |
| Aug 06, 2026 | 2026 (Q2) | -0.75-1.17 | 0.5 | -333.33% (-1.67) | |
| May 13, 2026 | 2026 (Q1) | -0.92-0.84 | -0.33 | -150.00% (-0.50) | |
| Mar 25, 2026 | 2025 (Q4) | -0.84-1.50 | -2.34 | 35.71% (+0.84) | |
| Nov 13, 2025 | 2025 (Q3) | -0.67-0.67 | -0.67 | 0.00% (+0.00) | |
| Aug 07, 2025 | 2025 (Q2) | -0.950.50 | -1.34 | 137.50% (+1.84) | |
| May 14, 2025 | 2025 (Q1) | ―-0.02 | -2 | 99.17% (+1.99) | |
| Mar 31, 2025 | 2024 (Q4) | -1.17-0.33 | -2 | 83.33% (+1.67) | |
| Nov 07, 2024 | 2024 (Q3) | -1.06-0.67 | -3.51 | 80.95% (+2.84) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
